Flywire Corp Q3 FY2024 earnings call

Management Statement and Operational Highlights: - Context and Achievements: Since IPO in 2021, Flywire doubled revenue and surpassed IPO objectives. Plans to double revenue again in coming years while improving profitability. Has 4,000+ clients in 50 countries and over 1,300 FlyMates. - Go-to-Market Capabilities: Data-driven approach to optimize revenue growth, prioritizes high ROI marketing, and held inaugural client conference in the US. - Flywire Advantage Expansion: Enabled $11 billion in total payment volume, strengthened global payment network with APAC partnerships, and enhanced payment acceptance capabilities. - FlyMate Community: Focus on building high-performance teams, supported FlyMates in Valencia, Spain affected by flooding.

Segment Performance: Revenue less ancillary services was $151.4 million in Q3 2024, representing a 29.6% year-over-year growth. Adjusted gross profit was $101.9 million, up 27.2% year-over-year. Adjusted EBITDA was $42.2 million, increasing by $14.7 million year-over-year with an adjusted EBITDA margin expansion of nearly 429 basis points. Product segments: Education had strong growth, travel saw growth, B2B had organic growth above average, and healthcare returned to modest growth. Education is a major revenue contributor, with travel, B2B, and healthcare also diversifying the revenue base.

Guidance: - Full Year 2024: Revenue expected in the range of $479 million to $485 million (26% growth midpoint). Adjusted EBITDA outlook raised to $76 million to $80 million. - Q4 2024: Revenue expected $118 million to $124 million, adjusted EBITDA $15 million to $19 million, in line with prior midpoints.

Risks: Regulatory headwinds from Canada and Australia imposing limits on foreign students, impacting education revenue growth. Canada-India political tensions and Canadian restrictive immigration policies, Australia's emerging regulatory developments pose challenges.

Question and Answer: Q: Discuss customer adds by verticals and drivers of growth.

A: Rob Orgel mentioned over 200 net new additions, with travel slightly above education, diversity across subsegments and geographies. Education had broad geographic distribution, B2B organic growth above average, and healthcare returned to growth.

Q: Regulatory risks in Australia and Canada.

A: Rob Orgel discussed Canada's demand destruction due to political and policy factors, Australia's emerging regulatory moderation, but continued opportunities in both markets.

Q: Capital allocation and M&A pipeline.

A: Mike Massaro talked about investing in business, evaluating M&A to accelerate growth, and ongoing share buyback, with focus on cultural fit and technology vision.

Q: Education business, including UK strength and student financial software.

A: Rob Orgel mentioned UK education vertical strength, student financial software as revenue multiplier, with go-to-market efforts to accelerate adoption.

Q: NRR and retention drivers.

A: Rob Orgel discussed NRR drivers including adoption/utilization, product expansion, and expanding customer profiles, with Canada's impact on corporate NRR but underlying drivers remain strong.

Q: Healthcare vertical growth.

A: Rob Orgel mentioned healthcare returned to growth through new clients and deepening partnerships, like Banner Health's integration.

Q: Australia growth moderation and penetration.

A: Rob Orgel explained moderation assumes proposed regulations, but continued opportunities to drive penetration through existing assets and platform.